Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegvisomant in Subjects With Insulin Resistance Without Diabetes
NCT02023918Phase 2Completed
- Sponsor
- University of California, San Francisco
- Start
- Jan 2014
- Primary completion
- Aug 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pegvisomant in insulin resistance (IR), sponsored by University of California, San Francisco. Started Jan 2014; status: completed.
02
Drugs
pegvisomant
03
Conditions
insulin resistance (IR)
Beyond the preview
Go deeper on NCT02023918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02023918.